Rani Therapeutics Holdings Inc Cl A (RANI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 18,618 | 4,144 | 10,216 | 10,111 | 3,762 |
| Marketable Securities | 31,091 | N/A | N/A | 5,742 | 23,877 |
| Receivables | 2,042 | N/A | N/A | 600 | N/A |
| Other current assets | 0 | 0 | 0 | 0 | 428 |
| TOTAL | $53,321 | $4,955 | $11,073 | $17,783 | $29,744 |
| Non-Current Assets | |||||
| PPE Net | 736 | 922 | 1,144 | 1,348 | 1,548 |
| Other Non-Current Assets | 4,564 | 4,262 | 4,681 | 4,994 | 5,342 |
| TOTAL | $5,300 | $5,184 | $5,825 | $6,342 | $6,890 |
| Total Assets | $58,621 | $10,139 | $16,898 | $24,125 | $36,634 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 13,537 | 15,000 | 15,000 | 15,000 |
| Accounts payable and accrued liabilities | 309 | 2,467 | 1,798 | 1,520 | 1,359 |
| Accrued Expenses | 3,943 | 2,091 | 2,636 | 2,285 | 2,073 |
| TOTAL | $12,669 | $19,144 | $20,623 | $20,130 | $19,891 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | 2,229 | 5,921 | 9,613 |
| Deferred Revenues | 6,831 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,501 | 5,470 | 7,731 | 8,897 | 10,412 |
| TOTAL | $4,440 | $2,968 | $5,428 | $9,344 | $13,250 |
| Total Liabilities | $17,109 | $22,112 | $26,051 | $29,474 | $33,141 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 123,692 | 121,512 | 71,869 | 57,542 | 57,482 |
| Common Shares | 11 | 6 | 5 | 5 | 5 |
| Retained earnings | -132,580 | -122,275 | -116,863 | -110,171 | -102,907 |
| Other shareholders' equity | 8,503 | -4,110 | -3,575 | -2,291 | 1,506 |
| TOTAL | $41,512 | $-11,973 | $-9,153 | $-5,349 | $3,493 |
| Total Liabilities And Equity | $58,621 | $10,139 | $16,898 | $24,125 | $36,634 |